Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 24,765	$ 11,231
Accounts receivable, net of allowance for doubtful accounts of $2,948 and $3,013, respectively	15,395	15,958
Inventory	14,744	18,515
Prepaid expenses and other current assets	4,957	5,558
Total current assets	59,861	51,262
Property and equipment, net	834	1,108
Right of use assets, net	1,928	2,260
Intangible assets, net	2,270	2,279
Other assets	1,035	1,195
Total assets	65,928	58,104
Current liabilities:
Accounts payable	30,841	30,432
Accrued and other expenses	14,038	19,984
Current portion of deferred revenues	1,042	1,148
Line of credit	0	4,685
Current portion of long-term debt	4,798	10,353
Total current liabilities	50,719	66,602
Long-term debt, net	3,500	0
Noncurrent lease liabilities	715	1,162
Common stock warrant liabilities	24,945	724
Other long-term liabilities	2,007	251
Total liabilities	81,886	68,739
Commitments and Contingencies
Stockholders’ equity (deficit):
Common stock, $0.0001 par value, 1,000,000,000 shares authorized as of March 31, 2023 and December 31, 2022; 117,465,938 and 115,388,135 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively.	12	12
Additional paid-in capital	214,135	212,111
Accumulated deficit	(234,625)	(222,758)
Total stockholders’ equity (deficit)	(20,478)	(10,635)
Total liabilities, convertible preferred stock, and stockholders’ equity (deficit)	65,928	58,104
Series A Convertible Preferred Stock
Current liabilities:
Series A convertible preferred stock, 0.0001 par value, 100,000,000 shares authorized as of March 31, 2023 and December 31, 2022; 30,000 and 0 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively (liquidation preference of $30,000)	$ 4,520	$ 0